Effect of dillenia pentagyna extract on sialic acid content and agglutinability of normal and tumor cells with concanavalin a and wheat germ agglutinin

International Journal of Zoological Research

Volumn 4, Issue 4, 2008, Pages 203-213

  Rosangkima, G ^a   Rongpi, T ^a   Prasad, S B ^a  

^a NORTH EASTERN HILL UNIVERSITY   (India)

Author keywords

Antitumor potential; Dalton's lymphoma; Release of sialic acid decreased agglutimbihty; Tumor cell lysis

Indexed keywords

DILLENIA PENTAGYNA; MUS; TRITICUM AESTIVUM;

EID: 70350351165     PISSN: 18119778     EISSN: 18119786     Source Type: Journal    
DOI: 10.3923/ijzr.2008.203.213     Document Type: Article

References (24)

1. Alasbahi, R.H., S. Safiyeva and L.E. Craker, 1999. Antimicrobial activity of some Yemeni medicinal plants. J. Herbs Spices Med. Plants, 6: 75-83.
2. Filipovic, I. and E. Buddecke, 1979. Role of net charge of low-density lipoproteins in high affinity binding and uptake by cultured cell. Biochem. Biophs. Res. Co., 88: 485-492.
3. Imberty, A., C. Gautier, J. Lescar, S. Perez, L. Wyns and R. Loris, 2000. An unusual carbohydrate binding site revealed by the structures of two Maackia amurensis lectins complexed with sialic acid-containing oligosaccharides. J. Biol. Chem., 275: 17541-17548.
4. Iwakawa, K., N. Ueda, S. Murao and N. Kobayashi, 1996. Altered carbohydrate composition in colorectal adenomas and carcinomas: Histochemical characterization of N-acetylgalactosamine, L-fucose and o-acetylated sialic acid. J. Gastroenterol., 31: 24-32.
5. Keiko, M., O. Katsuyuki, I. Mineko, K. Tetsufiuni and K. Kensuke et al., 2004. Loss of disialyl Lewisa, the ligand for lymphocyte inhibitory receptor sialic acid-binding immunoglobulin-like lectin-7 (siglec-7) associated with increased sialyl Lewisa expression on human colon cancers. Cancer Res., 64: 4498-4505.
6. Kelm, S. and R. Schauer, 1997. Sialic acids in molecular and cellular interactions. Int. Rev. Cytol., 175: 137-240.
7. Nicol, B.M. and S.B. Prasad, 2002. Sialic acid changes in Dalton's lymphoma-bearing mice after cyclophosphamide and cisplatintreatment. Braz. J. Med. Biol. Res., 35: 549-553.
8. Onodera, K., N. Yamaguchi, T. Kuchino and Y. Aoi, 1976. Alterations in surface glycoproteins and level of sialyltranferase of cells transformed by a temperature-sensitive mutant of SV40. Pak. J. Natl. Acad. Sci. USA, 73: 4090-4094.
9. Orekhov, A.N., V.V. Tertov, D.N. Mukhin and I. A. Mikhailenko, 1989. Modification of low density lipoprotein by desialylation causes lipid accumulation in cultured cells: discovery of desialylated lipoprotein with altered cellular metabolism in the blood of atherosclerotic patients. Biochem. Biophs. Res. Co., 162: 206-211.
10. Patricia de Albuquerque, G. R, C.V. Nakamura, W. De Souza and J.A. Morgado-Díaz, 2004. Differential expression of sialic acid and N-acetylgalactosamine residues on the cell surface of intestinal epithelial cells according to normal or metastatic potential. J. Histochem. Cytochem., 52: 629-640.
11. Peter, M.E., S. Hellbardt, R. Schwartz-Albiez, M.O. Westendorp and H. Walczak et al., 1995. Cell surface sialylation plays a role in modulating sensitivity towards APO-1-mediated apoptosic cell death. Cell Death Differ, 2: 163-171.
12. Prasad, S.B. and A. Giri, 1974. Antitumour effect of cisplatin against murine ascites Dalton's lymphoma. Indian J. Exp. Biol., 32: 155-162.
13. Prasad, S.B. and A. Sodhi, 1982. Effect of cis-dichlorodiammine platinum (II) on surface of tumor and normal cells: Biochemical, fluorescence and electron microscopical studies. Indian J. Exp. Biol., 20: 559-571.
14. Prasad, S.B., 1986. Studies on the sialic acid in tumor and normal cells using cisplatin as a probe. Curr. Sci. India, 55: 651-654.
15. Pulcinski, M.C., W.M. Riley, J.J. Prorok and J.A. Alhadeff, 1986. Total and lipid associated serum sialic acid levels in cancer patients with different primary sites and differing degrees of metastatic involvement. Cancer, 58: 2860-2865.
16. Rao, V.S. and M. Sirsi, 1973. Studies on sialic acid in Yoshida ascites sarcoma cells. Indian J. Biochem. Biol., 10: 37-41.
17. Remani, P., R. A Nair, T.T. Sreelekha, J. Madhavan, T. Vijayakumar and M.K. Nair, 2000. Altered expression of jack fruit lectin specific glycoconjugates in benign and malignant human colorectum. J. Exp. Clin. Cancer Res., 19: 519-523.
18. Rosangkima, G. and S.B. Prasad, 2004. Antitumour activity of some plants from Meghalaya and Mizoram against murine ascites Dalton's lymphoma. Indian J. Exp. Biol., 42: 981-988.
19. Sakagami, H., M. Ikeda, S. Unten, K. Takeda and J.I. Murayama et al., 1987. Antitumor activity of polysaccharide fractions from pine cone extract of Pinus parviflora Sieb. et Zucc. Anticancer Res., 7: 1153-1160.
20. Serdar, M.A., K. Yilmaz, A. Gunaydin, S. Tapan and K. Caglar et al, 2002. Sialic acid content of low-density lipoprotein in hemodialysis patients. Dialysis Transplant., 31: 97-105.
21. Stringou, E., K. Chondros, J. Kouvaris, S. Kakari and K. Papavassilious, 1992. Serum sialic acid (TSA/LSA) and carcinoembryonic antigen (CEA) levels in cancer patients undergoing radiotherapy. Anticancer Res., 12: 251-256.
22. Tiralongo, J. and R. Schauer, 2004. The enigma of enzymatic sialic acid O-acetylation. Trends Glycosci. Glycotechnol., 16: 1-15.
23. Warren, L., 1959. The thiobarbituric acid assay of sialic acids. J. Biol. Chem., 234: 1971-1975.
24. Warren, L., C.A. Buck and G.P. Tuszynski, 1978. Glycopeptide changes and malignant transformation. A possible role for carbohydrate in malignant behaviour. Biochim. Biophys. Acta, 516: 97-127.